Correlation Between VentriPoint Diagnostics and BONE BIOLOGICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and BONE BIOLOGICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and BONE BIOLOGICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and BONE BIOLOGICS P, you can compare the effects of market volatilities on VentriPoint Diagnostics and BONE BIOLOGICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of BONE BIOLOGICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and BONE BIOLOGICS.

Diversification Opportunities for VentriPoint Diagnostics and BONE BIOLOGICS

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between VentriPoint and BONE is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and BONE BIOLOGICS P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BONE BIOLOGICS P and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with BONE BIOLOGICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BONE BIOLOGICS P has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and BONE BIOLOGICS go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and BONE BIOLOGICS

Assuming the 90 days horizon VentriPoint Diagnostics is expected to generate 16.64 times less return on investment than BONE BIOLOGICS. But when comparing it to its historical volatility, VentriPoint Diagnostics is 3.22 times less risky than BONE BIOLOGICS. It trades about 0.03 of its potential returns per unit of risk. BONE BIOLOGICS P is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  90.00  in BONE BIOLOGICS P on January 17, 2025 and sell it today you would earn a total of  1,930  from holding BONE BIOLOGICS P or generate 2144.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy56.65%
ValuesDaily Returns

VentriPoint Diagnostics  vs.  BONE BIOLOGICS P

 Performance 
       Timeline  
VentriPoint Diagnostics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in VentriPoint Diagnostics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, VentriPoint Diagnostics reported solid returns over the last few months and may actually be approaching a breakup point.
BONE BIOLOGICS P 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BONE BIOLOGICS P has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in May 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

VentriPoint Diagnostics and BONE BIOLOGICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VentriPoint Diagnostics and BONE BIOLOGICS

The main advantage of trading using opposite VentriPoint Diagnostics and BONE BIOLOGICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, BONE BIOLOGICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BONE BIOLOGICS will offset losses from the drop in BONE BIOLOGICS's long position.
The idea behind VentriPoint Diagnostics and BONE BIOLOGICS P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets